Tag: AAD

All

Latest

Are Your Employees About to Quit?

In the first installment of a two-part article series, YellowTelescope President Jon Hoffenberg shares how data can uncover hidden insights in staff retention.

Sun Pharma Announces Long-term Insights into the Clinical Use of ILUMYA (tildrakizumab-asmn) in a Cross Section of People Living with Moderate-to-Severe Plaque Psoriasis

Sun Pharmaceutical Industries Ltd announces in a media release that one of its wholly owned subsidiaries presented further evidence of the long-term use and cost-effectiveness of ILUMYA (tildrakizumab-asmn) in moderate-to-severe plaque psoriasis at the American Academy of Dermatology (AAD) Virtual Meeting Experience 2020.

Read More
Loading